Clinical Trials Directory

Trials / Completed

CompletedNCT05600101

Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation

Development of Avatar-based Intervention to Support Patients Undergoing Reduced-Intensity Allogenic Stem Cell Transplantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this research study is to provide an avatar-based technology during a subject's stay for participants who have been admitted to the hospital for reduced-intensity conditioning (RIC) allogeneic transplant. The intervention received will be the care.coach technology.

Detailed description

This research study is a Pilot Study, which means the investigators are studying the application in a smaller group of people to understand whether the technology, care.coach, is easy to use. This is a single site study at Dana-Farber Brigham and Women's Cancer Center. * Aim 1 of the study will be an 8 - 10 participant focus group of nurses, navigator nurses, physicians, and NPs/PAs to refine the avatar protocols. * Aim 2 of the study will be a pilot of 18 participants undergoing RIC allogeneic HCT in the hospital. * The research study procedures include screening for eligibility, a brief call with a research assistant during use of care.coach avatar, and a survey after study completion. * The avatar is designed to communicate with participants regarding transplantation education and provide reminders for eating, drinking, and activity. * care.coach is a digital, avatar-based technology that communicates using natural speech software. * care.coach is supporting this research by providing Dana-Farber access to its technology. The National Cancer Institute (NCI) also supports this research.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCare.CoachCare.coach is a "human-in the-loop" conversational agent (avatar) used to interact and converse with patients through natural dialogue and text-to-speech software that is powered by a team of trained human staff, called health advocates.

Timeline

Start date
2022-12-06
Primary completion
2023-05-10
Completion
2023-05-16
First posted
2022-10-31
Last updated
2024-07-03
Results posted
2024-07-03

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05600101. Inclusion in this directory is not an endorsement.